These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 19883150)

  • 21. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):278-83. PubMed ID: 20846808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.
    Playford EG; Nimmo GR; Tilse M; Sorrell TC
    J Hosp Infect; 2010 Sep; 76(1):46-51. PubMed ID: 20382444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
    Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
    Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
    Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive candidiasis: an overview from Taiwan.
    Ruan SY; Hsueh PR
    J Formos Med Assoc; 2009 Jun; 108(6):443-51. PubMed ID: 19515624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
    Małafiej E; Adamiec AC; Tworzyańska U
    Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and outcome for nosocomial breakthrough candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
    Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
    Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for candidaemia in critically ill patients: a prospective surveillance study.
    Jordà-Marcos R; Alvarez-Lerma F; Jurado M; Palomar M; Nolla-Salas J; León MA; León C;
    Mycoses; 2007 Jul; 50(4):302-10. PubMed ID: 17576324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
    Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
    Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients.
    Vardakas KZ; Michalopoulos A; Kiriakidou KG; Siampli EP; Samonis G; Falagas ME
    Clin Microbiol Infect; 2009 Mar; 15(3):289-92. PubMed ID: 19154488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.